Stay updated with breaking news from Enabled Device Software Functions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In late September 2023, the U.S. Food and Drug Administration (FDA) released a draft guidance on “Regulatory Considerations for Prescription Drug Use-Related Software.” This guidance...
We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global contributors. In Industry Insights, we take an in-depth...
We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global…
Arnall Golden Gregory LLP's Food & Drug Newsletter is a roundup of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food &...
This first part of a two-part series on U.S. regulation of artificial intelligence systems provides an overview and modern context for the existing regulatory, legal and risk management...